Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: relations between study investigators, advisors, and sponsors. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis

Neurology. 1997 Mar;48(3):572-4. doi: 10.1212/wnl.48.3.572.

Authors

F D Lublin¹, S C Reingold

Affiliation

¹ Department of Neurology, Allegheny University of the Health Sciences, Philadelphia, PA 19129, USA.

PMID: 9065528
DOI: 10.1212/wnl.48.3.572

No abstract available

Publication types

Guideline

MeSH terms

Clinical Trials as Topic / standards*
Data Collection
Data Interpretation, Statistical
Humans
Informed Consent
Multiple Sclerosis / drug therapy*
Placebos
Research Design
Statistics as Topic

Substances

Placebos